This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1ap7

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1ap7.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1ap7.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1ap7| PDB=1ap7 | SCENE= }}
{{STRUCTURE_1ap7| PDB=1ap7 | SCENE= }}
-
'''P19-INK4D FROM MOUSE, NMR, 20 STRUCTURES'''
+
===P19-INK4D FROM MOUSE, NMR, 20 STRUCTURES===
-
==Overview==
+
<!--
-
In cancer, the biochemical pathways that are dominated by the two tumour-suppressor proteins, p53 and Rb, are the most frequently disrupted. Cyclin D-dependent kinases phosphorylate Rb to control its activity and they are, in turn, specifically inhibited by the Ink4 family of cyclin-dependent kinase inhibitors (CDKIs) which cause arrest at the G1 phase of the cell cycle. Mutations in Rb, cyclin D1, its catalytic subunit Cdk4, and the CDKI p16Ink4a, which alter the protein or its level of expression, are all strongly implicated in cancer. This suggests that the Rb 'pathway' is of particular importance. Here we report the structure of the p19Ink4d protein, determined by NMR spectroscopy. The structure indicates that most mutations to the p16Ink4a gene, which result in loss of function, are due to incorrectly folded and/or insoluble proteins. We propose a model for the interaction of Ink4 proteins with D-type cyclin-Cdk4/6 complexes that might provide a basis for the design of therapeutics against cancer. The sequences of the Ink4 family of CDKIs are highly conserved
+
The line below this paragraph, {{ABSTRACT_PUBMED_9353127}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 9353127 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_9353127}}
==About this Structure==
==About this Structure==
-
1AP7 is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1AP7 OCA].
+
1AP7 is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1AP7 OCA].
==Reference==
==Reference==
Line 32: Line 36:
[[Category: Cyclin dependent kinase inhibitor]]
[[Category: Cyclin dependent kinase inhibitor]]
[[Category: Ink]]
[[Category: Ink]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 10:32:41 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jun 30 17:20:23 2008''

Revision as of 14:20, 30 June 2008

Image:1ap7.png

Template:STRUCTURE 1ap7

P19-INK4D FROM MOUSE, NMR, 20 STRUCTURES

Template:ABSTRACT PUBMED 9353127

About this Structure

1AP7 is a Single protein structure of sequence from Mus musculus. Full experimental information is available from OCA.

Reference

Structure of the cyclin-dependent kinase inhibitor p19Ink4d., Luh FY, Archer SJ, Domaille PJ, Smith BO, Owen D, Brotherton DH, Raine AR, Xu X, Brizuela L, Brenner SL, Laue ED, Nature. 1997 Oct 30;389(6654):999-1003. PMID:9353127

Page seeded by OCA on Mon Jun 30 17:20:23 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1ap7"
Personal tools